Topic
Premarket Approval
34 published works
Regulatory Oversight
Tobacco Manufacturers and Retailers Sue the FDA Over Its Premarket Review Rule
On September 2, 2026, a group of tobacco product manufacturers and retailers filed a complaint in federal court, the U.S. District Court for the Northern District of Texas, challenging the…
Clark-Esposito Law Firm, P.C.
FDA Roundtable on ENDS PMTAs: More Clarity, Still No Clear Target
At its February 10, 2026 ENDS PMTA roundtable, FDA stressed that complete product data, strong manufacturing controls, and solid scientific evidence, especially for flavored products, are critical for authorization. While…
Tobacco Law Blog
Court Rules That Ohio AG Cannot Enforce FDA Premarket Authorization Requirements
An Ohio appellate court recently affirmed the dismissal of a case brought by the Ohio attorney general (AG) against Central Tobacco & Stuff Inc. (Central Tobacco), an e-cigarette retailer, in…
Drug & Device Law
No Cause of Action for Robbing the FDA of an Opportunity
If you’re a frequent visitor to the DDL blog, you’ll know all about products liability claims premised on defendants’ alleged failure to report adverse events to the FDA. You’ll also…
Drug & Device Law
PMA Preemption of Manufacturing Defect Claim: Long Time Coming
Federal preemption of tort claims involving medical devices receiving premarket approval (PMA) is a powerful defense. But for some reason, there are plaintiff lawyers who think it does not apply,…
Health Care and Life Sciences
FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company
By Dominick DiSabatino, Cortney Inman
On May 21, 2024, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) published a warning letter issued to Akan Biosciences, Inc. (Akan)…
Regulatory Oversight
Inside FDA’s Response to Reagan-Udall Foundation Report: Spotlight on the Science and Application Review Task Force
By Michael Jordan, Agustin Rodriguez, Bryan Haynes
This is the second post in our multipart series evaluating the Food and Drug Administration's response to the Regan-Udall Foundation report on the operations of the Center for Tobacco Products.…
The Continuum of Risk
FDA Files Civil Money Penalty Complaints Against Four Small Vape Shops for Alleged Premarket Review Violations
On February 22, 2023, the U.S. Food and Drug Administration (FDA) announced the filing of civil money penalty (CMP) complaints against four domestic e-liquid manufacturers, all of which appear to…
The Continuum of Risk
Partner Azim Chowdhury Authors Article on the Flaws of the Tobacco Control Act’s Premarket Authorization Requirement for New Tobacco Products in Filter
Keller and Heckman Partner Azim Chowdhury authored the Filter article, “Fundamental Flaws of Tobacco Control Act—and FDA’s Implementation,” published on November 14, 2022. The article discusses the Tobacco Control Act, passed by…
The Continuum of Risk
FDA Files Permanent Injunctions Against Six Small Vape Shops for Alleged Premarket Review Violations
On October 18, 2022, the U.S. Department of Justice (DOJ), on behalf of the U.S. Food and Drug Administration (FDA), filed complaints for permanent injunctions against six domestic e-liquid manufacturers…